Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |